Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Lisa M Pappas"'
Autor:
Danielle C. Sample, N. Jewel Samadder, Lisa M. Pappas, Kenneth M. Boucher, Wade S. Samowitz, Therese Berry, Michelle Westover, Deepika Nathan, Priyanka Kanth, Kathryn R. Byrne, Randall W. Burt, Deborah W. Neklason
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Patients with familial adenomatous polyposis (FAP) frequently undergo colectomy to reduce the 70 to 90% lifetime risk of colorectal cancer. After risk-reducing colectomy, duodenal cancer and complications from duodenal surgeries a
Externí odkaz:
https://doaj.org/article/ef08b6ae678041c8914dcf606b6811d8
Publikováno v:
BMC Pediatrics, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background Human Papillomavirus (HPV) vaccination coverage is below national goals in the United States. Research is needed to inform strategically designed interventions that target sociodemographic groups with underutilization of HPV vacci
Externí odkaz:
https://doaj.org/article/e9072272b1cd4587b5a18f2386a358b0
Autor:
Robert Lee Dood, Lisa M. Pappas, Lindsay J. Collin, Chelsey Vranes, Britton Trabert, Jennifer Anne Doherty
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: The degree to which uterine cancer metastatic to the ovary is misdiagnosed as synchronous stage I uterine and ovarian cancers is unclear. We sought to determine whether patients with synchronous cancers had mortality patterns similar to e
Autor:
Sunil Sharma, Joshua D. Schiffman, Bradley R. Cairns, William T. Lowrance, John M. O’Shea, Brian Dalley, Lisa M. Pappas, Alexis Weston, Andrew Butterfield, Timothy J. Parnell, Daniel J. Albertson, Sumati Gupta
Study Schema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d03082dfc96e6a789b51e7093790f38
https://doi.org/10.1158/1535-7163.22504728.v1
https://doi.org/10.1158/1535-7163.22504728.v1
Autor:
Sunil Sharma, Joshua D. Schiffman, Bradley R. Cairns, William T. Lowrance, John M. O’Shea, Brian Dalley, Lisa M. Pappas, Alexis Weston, Andrew Butterfield, Timothy J. Parnell, Daniel J. Albertson, Sumati Gupta
Swimmer Plot to show the best overall response and duration of benefit in seven bladder cancer patients from Table 1 treated with HDAC inhibition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7abb7b29048342a29e3e1e00fea1a0e2
https://doi.org/10.1158/1535-7163.22504725.v1
https://doi.org/10.1158/1535-7163.22504725.v1
Autor:
Deborah W. Neklason, Philip S. Bernard, Randall W. Burt, Kathryn R. Byrne, Priyanka Kanth, Inge J. Stijleman, Lisa M. Pappas, Kenneth M. Boucher, Kajsa E. Affolter, Wade S. Samowitz, N. Jewel Samadder, Angela K. Snow, Austin C. Wood, Don A. Delker
Endpoint only comparisons 3. Endpoint only comparisons (with all polyps, all 20 samples) a. Drug normal to polyp b. Placebo normal to polyp 4. Endpoint only excluding polyps < 50% tumor purity a. Drug normal to polyp b. Placebo normal to polyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c23d7d1ab18b9e0b0a541b606c9de34
https://doi.org/10.1158/1940-6207.22533635.v1
https://doi.org/10.1158/1940-6207.22533635.v1
Autor:
Sunil Sharma, Joshua D. Schiffman, Bradley R. Cairns, William T. Lowrance, John M. O’Shea, Brian Dalley, Lisa M. Pappas, Alexis Weston, Andrew Butterfield, Timothy J. Parnell, Daniel J. Albertson, Sumati Gupta
Histone deacetylase (HDAC) inhibition has sporadic clinical efficacy in urothelial carcinoma; the genomic basis for clinical response is not known. In two separate phase I clinical trials testing pharmacokinetic aspects of HDAC inhibitors in advanced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec4e1e38652dd7a79529d4ba01a40db4
https://doi.org/10.1158/1535-7163.c.6537834.v1
https://doi.org/10.1158/1535-7163.c.6537834.v1
Autor:
Sunil Sharma, Joshua D. Schiffman, Bradley R. Cairns, William T. Lowrance, John M. O’Shea, Brian Dalley, Lisa M. Pappas, Alexis Weston, Andrew Butterfield, Timothy J. Parnell, Daniel J. Albertson, Sumati Gupta
GSEA with Hallmark gene sets performed on transcriptional changes in HT1197 cells treated with panobinostat for 48 hours. A. Top 6 downregulated GSEA signatures B. Top 6 upregulated GSEA signatures C. GSEA HT1197 vs UMUC3 ( comparison of transcriptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3dc70c008073ca019badbdc66ba909
https://doi.org/10.1158/1535-7163.22504713
https://doi.org/10.1158/1535-7163.22504713
Autor:
Deborah W. Neklason, Philip S. Bernard, Randall W. Burt, Kathryn R. Byrne, Priyanka Kanth, Inge J. Stijleman, Lisa M. Pappas, Kenneth M. Boucher, Kajsa E. Affolter, Wade S. Samowitz, N. Jewel Samadder, Angela K. Snow, Austin C. Wood, Don A. Delker
Heat map of RNA expression showing all polyps including those with < 50% tumor purity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804cf6331bea55b33f83612be9a03141
https://doi.org/10.1158/1940-6207.22533650
https://doi.org/10.1158/1940-6207.22533650
Autor:
Sunil Sharma, Joshua D. Schiffman, Bradley R. Cairns, William T. Lowrance, John M. O’Shea, Brian Dalley, Lisa M. Pappas, Alexis Weston, Andrew Butterfield, Timothy J. Parnell, Daniel J. Albertson, Sumati Gupta
Heat map of top 50 genes affected in HT1197 cells when treated with panobinostat at 48 hours log2 gene expression change(HT1197 A-B and C represent control replicates, HT1197 Pano A, B, C represent treated replicates). For the cell lines with replica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0a56af42c97fabe3bfcd48fef55e9f8
https://doi.org/10.1158/1535-7163.22504722
https://doi.org/10.1158/1535-7163.22504722